Related Experiment Video
Updated: Jun 11, 2026
05:27
Stromal Cell Isolation From Hematopoietic Organs
Published on: January 26, 2024
Aging is not associated with bone marrow-resident progenitor cell depletion
Thomas J Povsic1, Jiying Zhou, Stacie D Adams
1Department of Medicine, Division of Cardiology, Duke University Medical Center, Durham, North Carolina 27705, USA. povsi001@mc.duke.edu
Summary
Aging reduces circulating progenitor cells but not bone marrow-resident progenitor cells in humans. This study clarifies age-related stem cell changes and impacts autologous marrow use for age-related diseases.
Area of Science:
- Gerontology
- Stem Cell Biology
- Hematology
Background:
- Progenitor cell biology is central to aging theories, yet human studies are limited.
- Aging is linked to declining circulating progenitor cells, but bone marrow progenitor cell changes are unclear.
- Understanding these changes is crucial for regenerative medicine and age-related disease treatments.
Purpose of the Study:
- To investigate age-related changes in human bone marrow-resident and circulating progenitor cells.
- To determine if bone marrow progenitor cell content declines with age in humans.
- To clarify the impact of aging on progenitor cell populations for therapeutic implications.
Main Methods:
- Enumeration of bone marrow and peripheral progenitor cells in patients undergoing hip replacement.
- Progenitor cell identification using aldehyde dehydrogenase activity and CD34/CD133 expression.
- Statistical analysis to assess age-related associations with progenitor cell counts.
Main Results:
- Circulating progenitor cells showed a significant age-dependent decline.
- Bone marrow-resident progenitor cell content did not correlate with age across all subtypes.
- No age-related depletion was observed in marrow-resident progenitor cells.
Conclusions:
- Human aging is characterized by a decrease in circulating progenitor cells, not marrow-resident ones.
- This dissociation suggests distinct mechanisms regulate circulating versus marrow-resident progenitor cell pools.
- Findings have significant implications for understanding stem cell aging and utilizing autologous marrow for age-related conditions.
Related Concept Videos
01:29Bone Disorders
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
01:19The Effect of Aging on Tissues
Several body functions deteriorate with age. The external signs of aging are easily identifiable. For example, the skin becomes dry, less elastic, and thins out, forming wrinkles. The skin of the face begins to appear looser due to a decrease in the levels of elastic and collagen fibers in the connective tissue. Additionally, melanin production in the hair follicle decreases with age, resulting in gray hair. Moreover, the senses of sight and hearing decline, so glasses and hearing aids may...
01:20Overview of Hematopoiesis
Hematopoiesis, or blood cell production, is a vital biological process that begins early in embryonic development and continues throughout life. This process generates the various types of cells found in blood, including red blood cells, white blood cells, and platelets from hematopoietic stem cells (HSCs).
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
01:21Hematopoiesis
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
01:15Differentiation of Common Myeloid Progenitor Cells
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
01:22Bone Marrow Sampling and Transplants
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...